Longitudinal toxicity analysis reveals chronic burden of cetuximab in metastatic colorectal cancer

♥ LIVING WITH CRC

A pooled analysis of 1,302 patients from the ARCAD database applied a longitudinal toxicity framework to compare chemotherapy with or without cetuximab, finding that traditional single worst-grade reporting may underrepresent chronic or recurrent toxicity burden. (Journal of the National Cancer Institute)